Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to dir... by M. Schwarz, C. Schwarz, A. Schütz, C. Schwanke, E. Krabb, R. Schubert, S.-T. Liebich, D. Bauer, L. Burghart, L. Brinkmann, E. Gutic, T. Reiberger, H. Haltmayer, M. Gschwantler

Get full text